Delivery Order SPE2DB20D6035-SPE2DB24FLXFH
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil. The $1,063.41 firm fixed price delivery order contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply this critical care medication to support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1 mg vials of the pharmaceutical Remifentanil. The $8,238.13 contract has an ultimate completion date of April 4, 2024 and does not utilize any set-aside designations. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 1 mg vials of the drug remifentanil. The $6,251.35 contract has an ultimate completion date of March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
This is a $1,787.42 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DX15D7067|SPE2DX24F2ZVJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,649.40 firm fixed-price delivery order is for the supply of 2 mg vials of the pharmaceutical product Remifentanil. The contract has a completion date of July 9, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $5,411.50 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply 4,563,552,518 vials of the drug Remifentanil 1 mg. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense,...
This federal contract award is for the delivery of 2 mg vials of the pharmaceutical drug remifentanil, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,782.48 firm fixed price delivery order contract is funded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2 mg vials of the medication Remifentanil. The contract has a firm fixed price of $3,039.11 and a completion date of June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,667.30, is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...